LabCompass

Richard Seonghun Nho

Medicine · The Ohio State University

Mid career · publishing since 2003Rising activity

Publications

67

Citations

2,885

Est. group size

~9

Recurring co-author estimate

Active years

24

Publishing since 2003

Research summary
AI-generated

Richard Seonghun Nho studies idiopathic pulmonary fibrosis (IPF), a chronic lung scarring disease, focusing on why lung scar-forming cells (fibroblasts) resist normal cell death and how this contributes to disease progression. His work also explores nanoparticle-based drug delivery systems as potential therapies to target these fibrotic cells and other lung conditions, including effects of inhaled particles like e-cigarette vapor.

Idiopathic pulmonary fibrosis and lung scarringFibroblast resistance to cell death (apoptosis)Nanoparticle-based drug delivery for lung diseaseDNA repair and cell survival signaling (CK2, FoxM1, mTOR)Respiratory effects of inhaled particles and nanomaterials

Publication output has been variable over the last decade, with a lull around 2020-2022 followed by a marked increase in output during 2023 and 2025.

Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026

Publication cadence
Publications per year over the last 10 years — averaging 5.0/year recently
2017: 2 publications172018: 4 publications182019: 4 publications192020: 2 publications20212022: 2 publications222023: 9 publications9232024: 4 publications242025: 8 publications252026: 2 publications26
Recent publications
Publishes in
  • American Journal of Respiratory and Critical Care Medicine×4
  • American Journal Of Pathology×2
  • Physiological Reports×2
  • Virology Journal×2
  • The FASEB Journal×2
Similar researchers
By research-topic overlap

This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.

Last updated Jul 19, 2026.

Claim or correct this profile